Negative regulation of onconstatin M signaling by suppressor of cytokine signaling (SOCS-3)

European Cytokine Network

Volumn 12, Issue 2, 2001, Pages 309-315

  Magrangeas, F ^a   Boisteau, O ^a   Denis, S ^a   Jacques, Y ^a   Minvielle, S ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Cytokine signaling; Inhibition; Jak STAT pathway

Indexed keywords

JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; ONCOSTATIN M; RAS PROTEIN; REGULATOR PROTEIN; STAT PROTEIN; SUPPRESSOR FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DIMERIZATION; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA CELL; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BASE SEQUENCE; DNA PRIMERS; ENZYME ACTIVATION; HUMANS; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOSTATIN M; PEPTIDES; PROTEINS; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

JANUS;

EID: 0034982578     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells
2. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor-beta-1, interferon-gamma, and oncostatin M for human melanoma cells
3. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells
4. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells
5. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology
6. Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells
7. Regulation of cell growth by recombinant oncostatin M
8. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor
9. The IL-6 signal transducer gp130: An oncostatin M receptor and affinity converter for the LIF receptor
10. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex
11. Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component
12. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
13. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components
14. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes
15. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a Jak1-dependent pathway
16. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes
17. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
18. Signaling of type II oncostatin M receptor
19. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions
20. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin-3 and erythropoietin receptors
21. CIS, a cytokine inducible SH2 protein, is a target of the Jak-STAT5 pathway and modulates STAT5 activation
22. A family of cytokine-inducible inhibitors of signaling
23. A new protein containing an SH2 domain that inhibits Jak kinases
24. Structure and function of a new STAT-induced STAT inhibitor
25. Cloning and expression of CIS6, chromosome assignment to 3p22 and 2p21 by in situ hybridization
26. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling
27. STAT3 and STAT4: Members of the family of signal transducers and activators of transcription
28. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation
29. Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade
30. Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signaling-3 (SOCS-3)
31. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
32. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
33. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling
34. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
35. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
36. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis